Analytical Data
-
基因名
LRRC29
- Application
-
别名
F box and leucine rich repeat protein 9 ; F box/LRR repeat protein 9 ; F-box and leucine-rich repeat protein 9; F-box protein FBL9; F-box/LRR-repeat protein 9; FBL9 ; FBXL9 ; Leucine rich repeat containing protein 29; Leucine-rich repeat-containing protein 29; LRC29_HUMAN; LRRC29
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8WV35
-
表达区间
1-233aa
-
氨基酸序列
MYSSGWPAGAAEPRHGRGRELAQALGCMHGAPSQLASLSLAHCSSLKSRPELEHQASGTKDACPEPQGPSLLTLRALQELDLTACSKLTDASLAKVLQFLQLRQLSLSLLPELTDNGLVAVARGCPSLEHLALSHCSRLSDKGWAQAASSWPRLQHLNLSSCSQLIEQTLDAIGQACRQLRVLDVATCPGINMAAVRRFQAQLPQVSCVQSRFVGGADLTLTL
-
分子量
50.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRRC29 (Leucine-rich repeat-containing protein 29) is a member of the leucine-rich repeat (LRR) protein family, which is characterized by a series of LRR motifs involved in protein-protein interactions and signaling pathways. Previous studies have implicated LRRC29 in various physiological processes, including cell signaling, immune responses, and development. Notably, it has been associated with certain diseases, particularly in the context of cancer, where its expression levels can influence tumor progression and metastasis. The precise functional roles of LRRC29, however, remain largely undefined. Therefore, the recombinant expression and characterization of LRRC29 have garnered attention as researchers aim to elucidate its structural properties and biological functions. By producing recombinant LRRC29, scientists can investigate its interactions with other cellular proteins and its downstream effects on signaling pathways. Understanding the biology of LRRC29 may reveal potential therapeutic targets for diseases where this protein is implicated. Moreover, the study of this protein could contribute to a broader understanding of LRR proteins in general, which play crucial roles in various cellular processes. Continued research into LRRC29's mechanisms may lead to novel insights into its role in health and disease, fostering advancements in targeted therapies and personalized medicine.
